- $7.27bn
- $8.14bn
- $2.74bn
- 87
- 30
- 90
- 79
Annual income statement for ESAB, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,950 | 2,428 | 2,593 | 2,775 | 2,741 |
Cost of Revenue | |||||
Gross Profit | 682 | 838 | 886 | 1,016 | 1,037 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,748 | 2,122 | 2,264 | 2,371 | 2,293 |
Operating Profit | 202 | 306 | 329 | 404 | 447 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 206 | 319 | 300 | 319 | 370 |
Provision for Income Taxes | |||||
Net Income After Taxes | 160 | 239 | 231 | 223 | 293 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 157 | 235 | 224 | 205 | 265 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 157 | 235 | 222 | 204 | 263 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.9 | 4.19 | 4.24 | 3.84 | 4.81 |
Dividends per Share |